Annual Working Capital
$5.94 M
-$1.25 M-17.45%
31 December 2023
Summary:
Cyclerion Therapeutics annual working capital is currently $5.94 million, with the most recent change of -$1.25 million (-17.45%) on 31 December 2023. During the last 3 years, it has fallen by -$35.61 million (-85.71%). CYCN annual working capital is now -92.84% below its all-time high of $82.95 million, reached on 31 December 2019.CYCN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.85 M
-$585.00 K-17.04%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly working capital is currently $2.85 million, with the most recent change of -$585.00 thousand (-17.04%) on 30 September 2024. Over the past year, it has dropped by -$4.67 million (-62.14%). CYCN quarterly working capital is now -97.68% below its all-time high of $122.78 million, reached on 30 June 2019.CYCN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.4% | -62.1% |
| 3 y3 years | -85.7% | -94.6% |
| 5 y5 years | +135.0% | -97.2% |
CYCN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -86.6% | at low | -94.6% | +254.2% |
| 5 y | 5 years | -92.8% | +135.0% | -97.2% | +254.2% |
| alltime | all time | -92.8% | +135.0% | -97.7% | +116.8% |
Cyclerion Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.85 M(-17.0%) |
| June 2024 | - | $3.43 M(-24.9%) |
| Mar 2024 | - | $4.57 M(-23.0%) |
| Dec 2023 | $5.94 M(-17.4%) | $5.94 M(-21.1%) |
| Sept 2023 | - | $7.52 M(+247.3%) |
| June 2023 | - | $2.17 M(+169.4%) |
| Mar 2023 | - | $804.00 K(-88.8%) |
| Dec 2022 | $7.19 M(-83.8%) | $7.19 M(-45.2%) |
| Sept 2022 | - | $13.13 M(-39.9%) |
| June 2022 | - | $21.83 M(-34.5%) |
| Mar 2022 | - | $33.34 M(-24.9%) |
| Dec 2021 | $44.37 M | $44.37 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $52.33 M(-16.2%) |
| June 2021 | - | $62.48 M(+101.7%) |
| Mar 2021 | - | $30.98 M(-25.4%) |
| Dec 2020 | $41.55 M(-49.9%) | $41.55 M(-22.9%) |
| Sept 2020 | - | $53.86 M(+22.6%) |
| June 2020 | - | $43.92 M(-25.2%) |
| Mar 2020 | - | $58.69 M(-29.2%) |
| Dec 2019 | $82.95 M(-588.9%) | $82.95 M(-18.4%) |
| Sept 2019 | - | $101.61 M(-17.2%) |
| June 2019 | - | $122.78 M(-842.6%) |
| Mar 2019 | - | -$16.53 M(-2.6%) |
| Dec 2018 | -$16.97 M(+32.8%) | -$16.97 M |
| Dec 2017 | -$12.78 M | - |
FAQ
- What is Cyclerion Therapeutics annual working capital?
- What is the all time high annual working capital for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual working capital year-on-year change?
- What is Cyclerion Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly working capital year-on-year change?
What is Cyclerion Therapeutics annual working capital?
The current annual working capital of CYCN is $5.94 M
What is the all time high annual working capital for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual working capital is $82.95 M
What is Cyclerion Therapeutics annual working capital year-on-year change?
Over the past year, CYCN annual working capital has changed by -$1.25 M (-17.45%)
What is Cyclerion Therapeutics quarterly working capital?
The current quarterly working capital of CYCN is $2.85 M
What is the all time high quarterly working capital for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly working capital is $122.78 M
What is Cyclerion Therapeutics quarterly working capital year-on-year change?
Over the past year, CYCN quarterly working capital has changed by -$4.67 M (-62.14%)